Professor Jens Juul Holst, MD, DMSc, is Professor of Medical Physiology at the University of Copenhagen and Senior Group Leader at the Novo Nordisk Foundation Center for Basic Metabolic Research
Thyroid Screening Before Starting Semaglutide Treatment Medical best practice recommends a baseline thyroid panelincluding TSH, free T4, and thyroid peroxidase (TPO) antibodiesbefore initiating semaglutide or any GLP-1 receptor agonist
Role of phosphodiesterase and adenylate cyclase isozymes in murine colonic glucagonlike peptide 1 secreting cells
If you become physically dependent on a substance, your body adapts to it, youll need more of it to get the same effect, and you may get withdrawal symptoms when you stop taking it
Clinical data suggests combined therapy produces 15-22% weight reduction over 24 weeks versus 8-12% with GLP-1 alone, but metabolic adaptation still occurs
The interchangeability standards that apply to biosimilars the clinical and pharmacokinetic data required to allow pharmacist-level substitution without prescriber authorization are stringent enough that very few biosimilars have achieved interchangeable status in the U.S
-(1).png?sfvrsn=c236e848_3)
